IMARC Group, a leading market research company, has recently releases report titled“Human Growth Hormone Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028“, The study provides a detailed analysis of the industry, including the global human growth hormone market trends, share, size, and growth forecasts. The report also includes competitor and regional analysis and highlights the latest advancements in the market.

Report Highlights:

How big is the human growth hormone market?

What are Human Growth Hormones?

Human growth hormone, also known as HGH, refers to a peptide hormone that is produced by the pituitary gland to stimulate growth in children and adults. It generally regulates the regeneration, repair, reproduction, and metabolism of the cells, thereby contributing to the overall development of the body. Human growth hormone also manages body fluids, fat metabolism, bone and muscle growth, etc. The deficiency of HGH can increase the risk of chronic diseases and fat accumulation, whereas higher levels can cause gigantism and acromegaly, muscle-wasting disease, short bowel syndrome in adults, etc.

Request for a free sample copy of this report: https://www.imarcgroup.com/human-growth-hormone-market/requestsample

Human Growth Hormone Market Trends:

The growing prevalence of Turner syndrome, which is a chromosomal disorder distinguished by complete or partial loss of X chromosomes, is among the key factors stimulating the human growth hormone market. Moreover, growth hormones are usually administered to reverse some of the symptoms of this disease, thereby escalating the demand for HGH drugs across countries. Besides this, the increasing consumer health consciousness, the development of recombinant human growth hormone (rHGH), and the inflating need for preventive measures against endocrine disorders are positively influencing the global market. Furthermore, the rising occurrence of disorders, including Prader-Willi syndrome (PWS) and idiopathic short stature (ISS) that are caused by the deficiency of growth hormones in the body and can be treated by using medically synthesized medications, is acting as another significant growth-inducing factor. Apart from this, the widespread adoption of HGH as performance enhancers by bodybuilders is anticipated to fuel the human growth hormone market over the forecasted period.

Who are the key players operating in the industry?

The report covers the major market players including:

• Eli Lilly and Company
• EMD Serono Inc.
• F. Hoffmann-La Roche AG
• Ferring B.V.
• Genentech Inc.
• Ipsen
• Merck KGaA
• Novartis AG
• Novo Nordisk
• Pfizer Inc.
• Sandoz, etc.

What is included in market segmentation?

The report has segmented the market into the following categories:

Breakup by Application:

• Growth Hormone (GH) Deficiency
  • Adult GH Deficiency
  • Pediatric GH Deficiency
• Turner Syndrome
• Idiopathic Short Stature (ISS)
• Prader-Willi Syndrome (PWS)
• Small for Gestational Age
• Others

Breakup by Distribution Channel:

• Hospital Pharmacy
• Retail Pharmacy
• Online Pharmacy
• Others

Breakup by Route of Administration:

• Intravenous
• Intramuscular
• Subcutaneous
• Oral

Breakup by Region:

• Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
• North America (United States, Canada)
• Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
• Latin America (Brazil, Mexico, Argentina, Colombia, Chile, Peru, Others)
• Middle East and Africa (Turkey, Saudi Arabia, Iran, United Arab Emirates, Others)

Ask Analyst for Customization and Browse full report with TOC & List of Figure:https://www.imarcgroup.com/human-growth-hormone-market

If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.

About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Our offerings include comprehensive market intelligence in the form of research reports, production cost reports, feasibility studies, and consulting services. Our team, which includes experienced researchers and analysts from various industries, is dedicated to providing high-quality data and insights to our clientele, ranging from small and medium businesses to Fortune 1000 corporations.

Contact US:

IMARC Group

134 N 4th St. Brooklyn, NY 11249, USA

USA: +1-631-791-1145 | Asia: +91-120-433-0800

Email: sales@imarcgroup.com

Follow us on Twitter: @imarcglobal

LinkedIn: https://www.linkedin.com/company/imarc-group/mycompany/